Michel Arock
Research Subjects
Research Interests
Michel Arock has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Jean-Jacques Guillosson
2 shared publicationsLiliane Le Goff
CNRS URA625, Hôpital de la Pitié-Salpêtrière, Paris, France
2 shared publicationsPatrice Debré
CNRS URA625, Hôpital de la Pitié-Salpêtrière, Paris, France
2 shared publicationsCamille Francès
1 shared publicationFrédéric Feger
Cellular and Molecular Hematology Unit, Faculty of Pharmacy , Paris, France
1 shared publicationFrédéric Féger
CNRS Unit FRE 2444
1 shared publication
Latest Publications
- 1 January 2004
- Published by Springer Nature
- p. 169-179
C-kit and Mastocytosis
- Open Access
- 1 February 2000
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 67 (2) , 135-148
c-Kit and c-kit mutations in mastocytosis and other hematological diseases
Mast cells (MC) are tissue elements derived from hematopoietic stem cells. Their differentiation and proliferation processes are under the influence of cytokines, including one of utmost importance known as stem cell factor (SCF). SCF receptor is encoded by the protooncogene c‐kit, belongs to the type III receptor tyrosine kinase subfamily, and is also expressed on other hematopoietic or non‐hematopoietic cells. Ligation of c‐kit receptor by SCF induces its dimerization, followed by induction of multiple intracellular signaling pathways leading to cell proliferation and activation. Mastocytosis, a relatively rare group of diseases characterized by accumulation of MC in various tissues, are found isolated or sometimes associated with other hematological malignancies in humans. Although the initial events leading to mastocytosis are not yet unraveled, alterations of the c‐kit gene have been described. Particularly interesting are acquired mutations resulting in a constitutively activated receptor, possibly involved in the increased numbers of MC in tissues. For this reason, future strategies might be envisaged to target specifically the mutated c‐kit and/or its intracellular signaling. J. Leukoc. Biol. 67: 135–148; 2000.
- 1 February 2000
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 67 (2) , 135-148
Open Accessc-Kit and c-kit mutations in mastocytosis and other hematological diseases
Mast cells (MC) are tissue elements derived from hematopoietic stem cells. Their differentiation and proliferation processes are under the influence of cytokines, including one of utmost importance known as stem cell factor (SCF). SCF receptor is encoded by the protooncogene c‐kit, belongs to the type III receptor tyrosine kinase subfamily, and is also expressed on other hematopoietic or non‐hematopoietic cells. Ligation of c‐kit receptor by SCF induces its dimerization, followed by induction of multiple intracellular signaling pathways leading to cell proliferation and activation. Mastocytosis, a relatively rare group of diseases characterized by accumulation of MC in various tissues, are found isolated or sometimes associated with other hematological malignancies in humans. Although the initial events leading to mastocytosis are not yet unraveled, alterations of the c‐kit gene have been described. Particularly interesting are acquired mutations resulting in a constitutively activated receptor, possibly involved in the increased numbers of MC in tissues. For this reason, future strategies might be envisaged to target specifically the mutated c‐kit and/or its intracellular signaling. J. Leukoc. Biol. 67: 135–148; 2000.
- 1 November 1997
- Published by Wiley in European Journal of Immunology
- Vol. 27 (11) , 2907-2913
Nitric oxide pathway is induced by FcεRI and up‐regulated by stem cell factor in mouse mast cells
Murine stem cell factor (SCF) induces the differentiation of mucosal mast cells (MMC) into connective tissue mast cells (CTMC) and potentiates mediator release induced by aggregation of high‐affinity IgE receptors (FcεRI). In the present work, we investigated the effect of FcεRI aggregation on nitric oxide (NO) pathway induction in the different subsets of mast cells, as well as the contribution of SCF in this induction. Inducible NO synthase (iNOs) expression was not evidenced in non‐stimulated MMC obtained by culture of hematopoietic progenitors in the presence of interleukin‐3, whereas IgE‐antigen‐stimulated MMC expressed iNOs mRNA and protein and synthesized nitrites. Long‐term treatment of MMC with SCF, allowing them to differentiate into CTMC, induced iNOs expression in non‐stimulated cells and up‐regulated iNOs expression and generation of NO derivatives induced by IgE‐antigen stimulation. Thus, NO derivatives generated by mast cells could participate in inflammatory reactions during allergic stimulation.
- 1 November 1997
- Published by Wiley in European Journal of Immunology
- Vol. 27 (11) , 2907-2913
Nitric oxide pathway is induced by FcεRI and up‐regulated by stem cell factor in mouse mast cells
Murine stem cell factor (SCF) induces the differentiation of mucosal mast cells (MMC) into connective tissue mast cells (CTMC) and potentiates mediator release induced by aggregation of high‐affinity IgE receptors (FcεRI). In the present work, we investigated the effect of FcεRI aggregation on nitric oxide (NO) pathway induction in the different subsets of mast cells, as well as the contribution of SCF in this induction. Inducible NO synthase (iNOs) expression was not evidenced in non‐stimulated MMC obtained by culture of hematopoietic progenitors in the presence of interleukin‐3, whereas IgE‐antigen‐stimulated MMC expressed iNOs mRNA and protein and synthesized nitrites. Long‐term treatment of MMC with SCF, allowing them to differentiate into CTMC, induced iNOs expression in non‐stimulated cells and up‐regulated iNOs expression and generation of NO derivatives induced by IgE‐antigen stimulation. Thus, NO derivatives generated by mast cells could participate in inflammatory reactions during allergic stimulation.
- Open Access
- 1 October 1997
- Published by Springer Nature in Molecular Medicine
- Vol. 3 (10) , 686-694
Inducible Nitric Oxide Synthase and Proinflammatory Cytokine Expression by Human Keratinocytes during Acute Urticaria
- 1 October 1997
- Published by Springer Nature in Molecular Medicine
- Vol. 3 (10) , 686-694
Open AccessInducible Nitric Oxide Synthase and Proinflammatory Cytokine Expression by Human Keratinocytes during Acute Urticaria